Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome

Christopher Straka, James Ying, Feng Ming Kong, Christopher D. Willey, Joseph Kaminski, D. W.Nathan Kim

Research output: Contribution to journalReview articlepeer-review

73 Scopus citations


Superior vena cava syndrome (SVCS) is a relatively common sequela of mediastinal malignancies and may cause significant patient distress. SVCS is a medical emergency if associated with laryngeal or cerebral edema. The etiologies and management of SVCS have evolved over time. Non-malignant SVCS is typically caused by infectious etiologies or by thrombus in the superior vena cava and can be managed with antibiotics or anti-coagulation therapy, respectively. Radiation therapy (RT) has long been a mainstay of treatment of malignant SVCS. Chemotherapy has also been used to manage SVCS. In the past 20 years, percutaneous stenting of the superior vena cava has emerged as a viable option for SVCS symptom palliation. RT and chemotherapy are still the only modalities that can provide curative treatment for underlying malignant etiologies of SVCS. The first experiences with treating SVCS with RT were reported in the 1970’s, and several advances in RT delivery have subsequently occurred. Hypo-fractionated RT has the potential to be a more convenient therapy for patients and may provide equal or superior control of underlying malignancies. RT may be combined with stenting and/or chemotherapy to provide both immediate symptom palliation and long-term disease control. Clinicians should tailor therapy on a case-by-case basis. Multi-disciplinary care will maximize treatment expediency and efficacy.

Original languageEnglish (US)
Article number229
Pages (from-to)1-13
Number of pages13
Issue number1
StatePublished - Dec 1 2016


  • Hypo-fractionation
  • Multi-modality therapy
  • Stenting
  • Superior vena cava syndrome (SVC syndrome, SVCS)
  • Thoracic malignancies

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome'. Together they form a unique fingerprint.

Cite this